BRCA1 and breast carcinoma: Consistent with these findings, Turner and colleagues reported that the loss of expression of Fhit, encoded by the long gene FHIT at the common fragile site, FRA3B, was more frequent in the BRCA1 mutant breast cancers than the sporadic breast cancers (Turner et al., 2002).